Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lipocine announced that Health Canada has approved TLANDO for testosterone replacement therapy in adult males. Verity Pharma is slated to launch the product in Canada by the end of 2026.
Health Canada has approved TLANDO capsules for testosterone replacement therapy in adult men with hypogonadism. Verity Pharma holds exclusive North American commercial rights and targets a Canadian launch by end-2026.